Selected article for: "antiviral therapeutic and public health threat"
Author: Zhao, Xinbin; Ding, Yuecheng; Du, Jing; Fan, Yubo
Title: 2020 update on human coronaviruses: One health, one world
  • Cord-id: lisndiwj
  • Document date: 2020_8_29
    • ID: lisndiwj
    Snippet: Since human coronavirus (HCoVs) was first described in the 1960s, seven strains of respiratory human coronaviruses have emerged and caused human infections. After the emergence of severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV), a pneumonia outbreak of coronavirus disease 2019 (COVID-19) caused by a novel coronavirus (SARS-CoV-2) has represented a pandemic threat to global public health in the 21st century. Without effectively
    Document: Since human coronavirus (HCoVs) was first described in the 1960s, seven strains of respiratory human coronaviruses have emerged and caused human infections. After the emergence of severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV), a pneumonia outbreak of coronavirus disease 2019 (COVID-19) caused by a novel coronavirus (SARS-CoV-2) has represented a pandemic threat to global public health in the 21st century. Without effectively prophylactic and therapeutic strategies including vaccines and antiviral drugs, these three coronaviruses have caused severe respiratory syndrome and high case-fatality rates around the world. In this review, we detail the emergence event, origin and reservoirs of all HCoVs, compare the differences with regard to structure and receptor usage, and summarize therapeutic strategies for COVID-19 that cause severe pneumonia and global pandemic.

    Search related documents:
    Co phrase search for related documents
    • accessory protein and active site: 1, 2
    • accessory protein and acute sars respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • accurate quick and acute sars respiratory syndrome: 1, 2, 3, 4, 5
    • acetyl esterase activity and active site: 1
    • acetyl esterase and active site: 1, 2
    • acgaac gene and acute sars respiratory syndrome: 1
    • ache muscle dyspnea fever and acute sars respiratory syndrome: 1
    • acid binding activity and acute sars respiratory syndrome: 1, 2
    • active site and acute sars respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25